Printer Friendly

Articles from The Fly (May 14, 2020)

1-140 out of 140 article(s)
Title Author Type Words
21Vianet Q1 EPS (3c), two estimates 0c. Financial report 212
3M reports total April sales down 11% y/y to $2.3B. Financial report 262
Abbott continuing to optimize ID NOW test as more info on virus comes. 334
Abbott's COVID-19 test failed to detect 48% of positive cases in study, WSJ says. Report 202
Advaxis announces clinical, biomarker data from Phase 1/2 ADXS-503 trial. 400
AIM ImmunoTech spikes 23% after FDA okays Ampligen trail in COVID-19 patients. 237
Akers says partner Premas 'successfully completed' COVID-19 vaccine prototype. 193
Alamos Gold announces ramp up of operations at Mulatos. 186
Alexion announces upcoming data presentations at virtual EHA meeting. 214
Alliance Communications Corporation initiates geophysics program. 309
Amazon launches Common Threads Vogue x Amazon Fashion. 221
Amazon to mass produce face shields for medical professionals. 269
Apple's global supply chain updates safety practices amid COVID-19, Verge says. 151
Applied DNA Sciences receives FDA EUA for COVID-19 assay kit. 160
Asian Market Update:. 214
AudioEye reports Q1 EPS (19c), consensus (23c). Financial report 183
Aurinia reports Q1 EPS (15c), consensus (15c). 244
Bioanalytical Systems reports Q2 EPS (5c) vs. (6c) last year. Financial report 178
BioXcel Therapeutics completes enrollment in Phase 3 SERENITY trials. 166
Caladrius reports 'positive' results for CLBS16 from ESCaPE-CMD trial. Financial report 176
Capstone Turbine provides update to business continuity plan. 507
Carlyle Group portfolio company acquires Tissue Analytics. 158
Carnival announces layoffs, furloughs, reduced work weeks, salary reductions. 321
Chicken Soup for the Soul reports Q1 ex-items EPS (87c), consensus (58c). Financial report 196
Chipotle partners with Uber Eats in Canada. 193
Clearway Energy divests residential solar portfolio, acquires Repowering 1.0. 173
Co-Diagnostics says COVID-19 test demonstrated 'excellent performance'. 222
Constellation Pharmaceuticals provides update of preliminary data for CPI-0610. 500
Corporacion America Airport reports April passenger traffic down 98.3%. 193
Covetrus reports Q1 EBITDA $48M versus $50M in Q1 last year. Financial report 182
CSP Inc. reports Q2 EPS (18c) vs. (15c) last year. Financial report 199
CVS Health to establish up to 1,000 COVID-19 test sites by end of May. 173
Dare Bioscience reports Q1 EPS (18c), consensus (29c). Financial report 183
Delta Air Lines authorizes plan to retire Boeing 777 aircraft. 201
Denny's reports Q1 EPS 17c, consensus 13c. Financial report 154
Eni names Claudio Descalzi CEO. 234
Enphase Energy chosen by Flywheel Development for solar projects. 219
EnWave signs technology evaluation, license option agreement with NuWave. 194
Equifax names Cecilia Mao as Chief Product Officer. 155
Exact Sciences announces results from Oncotype DX clinical survey at ASCO. Clinical report 363
Facebook's 2Africa internet project moves ahead with partners. 279
Farfetch reports Q1 EPS (24c), consensus (33c). Financial report 207
FDA alerts over potential inaccurate results from Abbott ID NOW COVID-19 test. 343
Fennec reports Q1 EPS (19c), consensus (19c). Financial report 178
First Majestic reports Q1 adj. EPS 4c, two est. (2c). Financial report 211
Flowr announces partnership with Terrace Global to fund Holigen. 598
Fly Intel: Top five analyst downgrades. 248
Fly Intel: Top five analyst upgrades. 175
Fortive, PSL form joint innovation studio. 191
Fortuna Silver Mines reports Q1 adj. EPS (1c), consensus 11c. Financial report 168
Frequency Therapeutics announces data from FX-322 exploratory clinical study. Clinical report 316
FX Action: USD-CAD has settled just off the one-week high. 248
FX Update: The dollar and yen have picked up safe haven demand. 307
FX Update: The dollar and yen have picked up safe haven demand. 304
GDS Holdings reports Q1 EPS (RMB0.09) vs. (RMB0.15). Financial report 152
Guardion Health Sciences reports Q1 revenue $245,723 vs. $242,538 last year. Financial report 224
Gulf Resources files Form 12b-25. 210
H&R Block intends to terminate Program Management Agreement with Axos Financial. 229
HC2 Holdings, MG Capital announce settlement agreement to reconstitute board. 295
Histogen publishes preclinical data on HST 004 Spinal Disc program. 227
Hookipa Pharma reports Q1 EPS (43c), consensus (42c). Financial report 184
Hookipa Pharma says on track to file HB-202 initial new drug submission in 1H20. 183
Immunovant achieves first earnout milestone under share exchange agreement. 512
INmune Bio reports Q1 EPS (19c), consensus (21c). Financial report 157
Inovio's INO-5401 combination shows 85% survival in glioblastoma. 185
Intelsat, certain subsidiaries file voluntary Chapter 11 petitions. 543
JPMorgan 'incrementally more positive' on SmileDirectClub after earnings call. 178
Kaleido Biosciences begins clinical study of KB109 in COVID-19 patients. 205
Kemet reports Q4 adj. EPS 37c, two est.17c. Financial report 215
Kitov Pharmaceuticals to present Phase 1 data on CM-24. 199
Krystal Biotech announces interim results from Phase 1/2 trial of KB105. Clinical report 287
Laredo Petroleum announces 1-for-20 reverse stock split. 212
Marrone Bio's REGALIA MAXX receives approval for use on cannabis, hemp. 192
Melco Resorts & Entertainment reports Q1 EPS (76c), consensus (43c). Financial report 623
Milestone Pharmaceuticals reports Q1 EPS (67c), consensus (74c). Financial report 223
MIND C.T.I. reports Q1 EPS 6c vs. 8c last year. Financial report 151
Morgan Stanley estimates $650M of 2021 synergies possible in GrubHub-Uber tie-up. 158
MorphoSys announces long-term follow-up results from L-MIND study of tafasitamab. 220
Motus GI Holdings reports Q1 EPS (23c), consensus (22c). Financial report 271
MTBC reaffirms FY20 revenue view $100M-$102M, consensus $98.1M. 212
MTBC, Inc reports Q1 adj. EPS 3c, consensus (64c). Financial report 235
NantKwest, ImmunityBio to initiate Phase 2 immunotherapy study. 250
NeuBase Therapeutics reports Q2 EPS (26c), consensus (22c). Financial report 299
New Relic reports Q4 adjusted EPS 14c, consensus 3c. 152
Nice reports Q1 EPS $1.34, consensus $1.31. Financial report 328
Nike sees accelerated new member acquisition amid COVID-19. 409
Nike sees higher inventory having material impact on NA business in Q4. 171
Norwegian Cruise Line develops strategy to enhance health, safety protocols. 175
Norwegian Cruise Line reaffirms withdrawal of 2020 guidance. 373
Norwegian Cruise Line sees approx $70M-$110M per month costs during suspension. 612
Norwegian Cruise Line sees demand for cruises beginning in Q4. 289
NY Governor Cuomo says U.S. House proposed a 'good bill'. 249
Ocular Therapeutix, Regeneron extend cooperation on eye treatment. 283
Office Depot announces restructuring plan, to cut 13,100 employees by 2023. 290
Organigram announces first phase of return-to-work strategy. 255
Patent attorney finds Amarin appeal brief effective, says H.C. Wainwright. 198
PetIQ announces proposed convertible senior notes offering to fund Capstar deal. 356
Pfizer announces 'positive' results from Phase 3 pneumococcal vaccine study. Report 159
Pluristem provides 28-day follow up for ventilator-dependent COVID-19 patients. 263
Postal Realty Trust reports Q1 AFFO 21c, consensus 22c. 222
PowerFleet reports Q1 EPS (16c), consensus (2c). Financial report 473
Predictive Oncology licensing NSP10 technology for COVID-19 vaccine. 316
Probe Metals completes acquisition of 100% interest in Detour Quebec project. 187
Quest Resource reports Q1 EPS (2c), consensus (2c). Financial report 174
Rapt Therapeutics reports Q1 EPS (56c), consensus (43c). Financial report 167
Sanofi announces FDA priority review of sutimlimab. 171
Sanuwave Health to deliver dermaPACE to patients in home setting. 279
Sapiens reports Q1 EPS 13c, consensus 19c. Financial report 236
Sierra Oncology reports positive dose intensity and safety data at EHA Congress. 182
SmileDirectClub appoints new members to clinical advisory board. 345
Sol-Gel Technologies reports Q1 EPS (33c), consensus (38c). Financial report 186
Solid Biosciences presents data from DMD Gene Therapy Program. 294
Soliton reports Q1 EPS (19c), consensus (25c). Financial report 203
Sonim reports Q1 EPS (48c), consensus (27c). Financial report 184
Stratasys reports Q1 EPS (19c), consensus (5c). Financial report 176
Sunnova Energy reports Q1 EPS (85c), consensus (12c). Financial report 373
SurveyMonkey updates app integration with Microsoft Teams. 186
Tapestry begins store reopening process in North America, Europe, Asia. 281
TCR2 Therapeutics reports Q1 EPS (65c), consensus (60c). Financial report 226
The -195k initial claims drop. 246
The U.S. trade price indexes. 172
Tracon Pharmaceuticals presents clinical data for Envafolimab. 276
Treasury Market Outlook: equities remain jittery and have extended lower overnight. 251
Treasury's $150 B 4- and 8-week bill auctions were well received. 192
Tronox to acquire Norwegian titanium smelting facility. 198
TSMC to build advanced semiconductor chip factory in Arizona, WSJ says. 168
U.S. April import prices dropped -2.6% and export prices were down -3.3%. 194
U.S. equity futures are weaker. 163
Ubisoft reports Q4 net bookings EUR417.4M, down 38.3%. 256
uniQure presents preclinical data in SCA3, Fabry Disease, Hemophilia A. 923
Vaccinex CEO says doesn't see trials 'materially impacted' by pandemic. 216
VBL Therapeutics reports Q1 EPS (15c), consensus (17c). Clinical report 201
Verona Pharma 'very pleased' with FDA response to End-of-Phase 2 briefing. 272
Vertex Energy reports Q1 EPS (21c), consensus (3c). Financial report 371
Wells Fargo, Goldman Sachs merger speculation 'unfounded,' says JPMorgan. 161
Whirlpool, Dow Inc., Reynolds announce PPE collaboration. 318 reports Q1 EPS (1c), consensus (3c). Financial report 165 sees Q2 revenue $231M-$233M, consensus $227.49M. Financial report 155 withdraws FY20 guidance, not providing guidance for second half of FY20. 206
X4 Pharmaceuticals discloses efficacy, safety data from mavorixafor trial. 302

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters